|
|
|
11-50 employees
View all
|
|
non-profit organization management
|
|
One Broadway 14th Floor,Cambridge,MA,US
|
|
Founded in 1994, the Angiogenesis Foundation is the world’s first 501(c)(3) nonprofit organization dedicated to conquering disease using a new approach based on angiogenesis, the growth of new capillary blood vessels in the body. We have identified angiogenesis as the “common denominator” in society’s most feared diseases. Our focus on this underlying process of many different diseases makes our approach as a medical organization unique. The Foundation is the recognized, expert voice and champion of this new field of medicine. Based in Cambridge, Massachusetts, the Angiogenesis Foundation’s goal is to help people lead healthier, longer lives by restoring balance to blood vessel growth. Through research, education, and advocacy — with patients, physicians, researchers, industry, payers, and government — we enable patients to gain access to safe and effective treatments coming from the angiogenesis field for cancer, blinding diseases, wounds, and many other serious diseases. As a scientific organization, the Angiogenesis Foundation is independent of any individual, institution, or commercial entity. We are committed to helping people around the world benefit from the full promise of angiogenesis-based medicine, and to make life-, limb-, and vision-saving treatments available to everyone in need.
|
The Angiogenesis Foundation Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{l} | [email protected] |
100%
|
The widely used The Angiogenesis Foundation email format is {first}.{l} (e.g. [email protected]) with 100% adoption across the company.
To contact The Angiogenesis Foundation customer service number in your country click here to find.
De Coux Charles Antoine is the CEO of The Angiogenesis Foundation.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.